QA: Organon & Co. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001821825_2023_Organon_Co.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001821825, Organon & Co.

  xvar xval
0 AssetsCurrent 3,931,000,000
1 IntangibleAssetsNetIncludingGoodwill 5,252,000,000
2 PropertyPlantAndEquipmentNet 1,018,000,000
3 remainder_Assets 754,000,000
4 LiabilitiesCurrent 2,512,000,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 2,294,000,000
8 SellingGeneralAndAdministrativeExpense 1,704,000,000
9 ResearchAndDevelopmentExpense 471,000,000
10 remainder_Expenses 788,000,000
11 remainder_Revenues 6,174,000,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome -51,000,000
  yvar yval
0 Assets 10,955,000,000
1 Liabilities 2,512,000,000
2 Expenses 5,257,000,000
3 Revenues 6,174,000,000
4 StockholdersEquity 8,443,000,000
5 NetIncome 917,000,000
6 ComprehensiveNetIncome 891,500,000
7 BaseVar 12,474,500,000
8 EconomicCapitalRatio 2.29

Edgar->Model Mapping

Feature Distribution

Change over Time